Last updated on September 2014

Study for Type 2 Diabetic subjects with high risk of cardiovascular events.


Brief description of study

Study for Type 2 Diabetic subjects with high risk of cardiovascular events.

Detailed Study Description

This clinical trial compares insulin degludec to insulin glargine in type 2 diabetic patients with high risk of cardiovascular events. All subjects receive active medication-there is no placebo.

Clinical Study Identifier: TX139224

Find a site near you

Start Over

Tampa Clinical Research

4278 W. Linebaugh Avenue Tampa, FL USA
  Connect »